参考文献/References:
[1]Wen H,Gris D,Lei Y,et al.Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling[J].Nature immunology,2011,12(5):408-415.
[2]Pushpakumar S,Kundu S.Endothelial dysfunction:the link between homocysteine and hydrogen sulfide[J].Current Medicinal Chemistry,2014,21(32):3662-3672.
[3]刘鹏,高学良,原建华,等.H型高血压患者血清同型半胱氨酸水平与冠状动脉狭窄病变程度的关系[J].中华老年心脑血管病杂志,2017,19(3):245-247.
[4]Lai WK,Kan MY.Homocysteine-Induced Endothelial Dysfunction[J].Ann Nutr Metab,2015,67(1):1-12.
[5]Fu Y,Wang X,Kong W.Hyperhomocysteinaemia and vascular injury:advances in mechanisms and drug targets[J].British Journal of Pharmacology,2018,175(8):1173-1189.
[6]Ference BA,Ginsberg HN,Graham I,et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease.1.Evidence from genetic,epidemiologic,and clinical studies.A consensus statement from the European Atherosclerosis Society Consensus Panel[J].European Heart Journal,2017,38(32):2459-2472.
[7]Libby P,Lichtman AH,Hansson GK.Immune effector mechanisms implicated in atherosclerosis:from mice to humans[J].Immunity,2013,38(6):1092-1104.
[8]Grebe A,Hoss F,Latz E.NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis[J].Circulation Research,2018,122(12):1722-1740.
[9]谭红梅.同型半胱氨酸激活NLRP3炎症小体促进动脉粥样硬化的作用研究[J].中国病理生理杂志,2015(10):1813-1814.
[10]Tschopp J,Schroder K.NLRP3 inflammasome activation:The convergence of multiple signalling pathways on ROS production[J].Nature Reviews Immunology,2010,10(3):210-215.
[11]Xi H,Zhang Y,Xu Y,et al.Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells[J].Circulation Research,2016,118(10):1525-1539.
[12]Shao BZ,Cao Q,Liu C.Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases[J].Frontiers in Molecular Neuroscience,2018(11):320.
[13]Sun W,Pang Y,Liu Z,et al.Macrophage inflammasome mediates hyperhomocysteinemia-aggravated abdominal aortic aneurysm[J].Journal of Molecular and Cellular Cardiology,2015,81(2):96-106.
[14]Ochoa CD,Wu RF,Terada LS.ROS signaling and ER stress in cardiovascular disease[J].Molecular Aspects of Medicine,2018,63(3):18-29.
[15]Konior A,Schramm A,Czesnikiewicz-Guzik M,et al.NADPH oxidases in vascular pathology[J].Antioxidants&Redox Signaling,2014,20(17):2794-2814.
[16]Montezano AC,Touyz RM.Oxidative stress,Noxs,and hypertension:Experimental evidence and clinical controversies[J].Annals of Medicine,2012,44(sup1):S2-S16.
[17]Bao XM,Wu CF,Lu GP.Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK[J].Atherosclerosis,2010,210(1):114-121.
[18]Ma MW,Wang J,Dhandapani KM,et al.NADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury[J].Oxidative Medicine and Cellular Longevity,2017(2017):6057609.
[19]Van Bruggen R,Koker MY,Jansen M,et al.Human NLRP3 inflammasome activation is Nox1-4 independent[J].Blood,2010,115(26):5398-5400.
[20]Takac I,Schroder K,Brandes RP.The Nox family of NADPH oxidases:friend or foe of the vascular system[J].Current Hypertension Reports,2012,14(1):70-78.
[21]Van De Veerdonk FL,Smeekens SP,Joosten L AB,et al.Reactive oxygen species-independent activation of the IL-1 inflammasome in cells from patients with chronic granulomatous disease[J].Proceedings of the National Academy of Sciences,2010,107(7):3030-3033.
[22]杨仁强,黄玲,马晓欣,等.NLRP3炎症小体介导血管紧张素Ⅱ诱导的人脐静脉血管内皮细胞炎症因子IL-1β的表达[J].南方医科大学学报,2016,36(6):790-795.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(15):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]王立民,刘有旺,王恩波,等.以大黄素为声敏剂介导声动力疗法对小鼠
动脉粥样硬化治疗作用的研究[J].医学信息,2018,31(06):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
WANG Li-min,LIU You-wang,WANG En-bo,et al.Study on the Effect of Emodin on the Treatment of Atherosclerosis in Mice[J].Journal of Medical Information,2018,31(15):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
[3]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Journal of Medical Information,2022,35(15):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[4]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对
糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Journal of Medical Information,2018,31(15):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[5]陈玉媛,易爱姣,谭齐鸣,等.中青年冠状动脉粥样硬化患者颈动脉硬化的超声特征[J].医学信息,2019,32(02):175.[doi:10.3969/j.issn.1006-1959.2019.02.054]
CHEN Yu-yuan,YI Ai-jiao,TAN Qi-ming,et al.Ultrasound Characteristics of Carotid Atherosclerosis in Young and Middle-aged Patients with Coronary Atherosclerosis[J].Journal of Medical Information,2019,32(15):175.[doi:10.3969/j.issn.1006-1959.2019.02.054]
[6]张 波.冠心病心绞痛患者血浆同型半胱氨酸水平与
中医证候要素痰、瘀的回归性研究[J].医学信息,2018,31(16):142.[doi:10.3969/j.issn.1006-1959.2018.16.045]
ZHANG Bo.A Regression Study of Plasma Homocysteine Level and Phlegm and Blood Stasis in Patients with Angina Pectoris of Coronary Heart Disease[J].Journal of Medical Information,2018,31(15):142.[doi:10.3969/j.issn.1006-1959.2018.16.045]
[7]吴彦卿.妊娠期同型半胱氨酸和血脂水平对重度子痫前期的预测价值[J].医学信息,2018,31(16):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
WU Yan-qing.Predictive Value of Homocysteine and Blood Lipid Levels during Pregnancy in Severe Preeclampsia[J].Journal of Medical Information,2018,31(15):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
[8]闫宇梅.血清胱抑素C及同型半胱氨酸与2型糖尿病
视网膜病变的相关性分析[J].医学信息,2018,31(17):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
YAN Yu-mei.Correlation between Serum Cystatin C and Homocysteine and Type 2 Diabetic Retinopathy[J].Journal of Medical Information,2018,31(15):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
[9]杨玉媛,刘有旺,李 腾,等.Th17细胞对动脉粥样硬化斑块易损性和斑块破裂的影响研究[J].医学信息,2018,31(18):53.[doi:10.3969/j.issn.1006-1959.2018.18.017]
YANG Yu-yuan,LIU You-wang,LI Teng,et al.Effect of Th17 Cells on Atherosclerotic Plaque Vulnerability and Plaque Rupture[J].Journal of Medical Information,2018,31(15):53.[doi:10.3969/j.issn.1006-1959.2018.18.017]
[10]薛 一,孔莫维,高 宇.脂蛋白相关磷脂酶A2与冠心病的研究[J].医学信息,2019,32(12):53.[doi:10.3969/j.issn.1006-1959.2019.12.017]
XUE Yi,KONG Mo-wei,GAO Yu.Research on Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease[J].Journal of Medical Information,2019,32(15):53.[doi:10.3969/j.issn.1006-1959.2019.12.017]